MedPath

Bi-level vs. Single Level ESB in VATS

Not Applicable
Conditions
Acute Pain
Interventions
Procedure: Bi-level erector spinae block
Procedure: Single level erector spinae block
Registration Number
NCT05294315
Lead Sponsor
Lawson Health Research Institute
Brief Summary

Video assisted thoracoscopic surgery (VATS) is a minimally invasive surgery to remove lesions from the thoracic cavity. It is associated with moderate pain which can lead to pulmonary complications after surgery. The Enhanced Recovery After Surgery (ERAS) and the European Society of Thoracic Surgeons recommended a multimodal analgesia approach to manage pain after VATS. Erector spinae block (ESB) is a popular analgesic block due to its ease of performance and wide coverage. It has been shown to be effective in randomized control trials. Recently, case reports on bi-level ESB are emerging, suggesting more effective analgesia compared to single level ESB. As there is no available data, the investigators are interested in conducting a randomized pilot study, comparing bi-level to single level ESB to gather baseline data for sample size calculation for a formal randomized trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • adult patients (at least 18 years old)
  • elective unilateral wedge resection, segmentectomy, lobectomy or bilobectomy via VATS
Exclusion Criteria
  • history of malignant hyperthermia
  • BMI > 40, chronic pain condition
  • Daily opioid consumption of more than 60 mg oral morphine equivalents
  • Conversion to thoracotomy
  • Insertion of epidural
  • postoperative admission to ICU

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bi-level block arm - InterventionBi-level erector spinae blockBi-level erector spinae block at 4th and 6th transverse process
Single level block arm - ControlSingle level erector spinae blockSingle level erector spinae block at 4th transverse process
Primary Outcome Measures
NameTimeMethod
Opioid use in first 12 postoperaive hourFirst 12 hour from arriving at postoperative recovery
Secondary Outcome Measures
NameTimeMethod
Incidence of Delayed block complication - based on clinical assessmentFirst 5 days

paresthesia, motor weakness, hematoma, abscess

Pain score area under curve first 12 hourFirst 12 hour from arriving at postoperative recovery

Numeric rating scale, 0 to 10, 0 being no pain and 10 being the worst possible pain

Incidence of Acute block complication - based on clinical assessmentFirst 12 hour since block placement

pneumothorax, local anesthetic toxicity, epidural spread, bleeding

Pain score area under curve first 24 hourFirst 24 hour from arriving at postoperative recovery

Numeric rating scale, 0 to 10, 0 being no pain and 10 being the worst possible pain

Trial Locations

Locations (1)

Cheng Lin

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath